Literature DB >> 15982303

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

Luigi Naldi1, Liliane Chatenoud, Dennis Linder, Anna Belloni Fortina, Andrea Peserico, Anna Rosa Virgili, Pier Luigi Bruni, Vito Ingordo, Giovanni Lo Scocco, Carmen Solaroli, Donatella Schena, Annalisa Barba, Anna Di Landro, Enrico Pezzarossa, Fabio Arcangeli, Claudia Gianni, Roberto Betti, Paolo Carli, Alessandro Farris, Gian Franco Barabino, Carlo La Vecchia.   

Abstract

We conducted a case-control study to analyse the association of psoriasis of recent onset with smoking habits, body mass index (BMI) and stressful life events. Cases (n=560; median age 38) were patients with a first diagnosis of psoriasis and a history of skin manifestations of no longer than two years after the reported disease onset. Patients with a new diagnosis of skin diseases other than psoriasis (n=690; median age 36) were selected as controls. The risk of psoriasis was higher in ex- and current smokers than in never-smokers, the relative risk estimates (OR) being 1.9 for ex-smokers and 1.7 for smokers. Smoking was strongly associated with pustular lesions (32 patients, OR=5.3 for smokers). The frequency of psoriasis varied significantly in relation to a family history of psoriasis in first degree relatives, BMI (OR=1.6 and 1.9 for over weighted, BMI 26-29, and obese, BMI >/= 30, respectively) and stressful life event score (compared to the lower index quartile, the OR being 2.2 for index values >/=115). Risk estimates, when taking into consideration the combined effect of these factors with smoking habits, were consistent with a multiplicative model of risk combination with no significant statistical interaction.

Entities:  

Mesh:

Year:  2005        PMID: 15982303     DOI: 10.1111/j.0022-202X.2005.23681.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  125 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 2.  Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Authors:  Lotus Mallbris; Christopher T Ritchlin; Mona Ståhle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

3.  Smoking and the risk of psoriasis in women: Nurses' Health Study II.

Authors:  Arathi R Setty; Gary Curhan; Hyon K Choi
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

Review 4.  Update on the natural history and systemic treatment of psoriasis.

Authors:  Stephen K Richardson; Joel M Gelfand
Journal:  Adv Dermatol       Date:  2008

5.  Clinico-biochemical correlation between psoriasis and insulin resistance.

Authors:  Suparna Dhara; Anindya Dasgupta; Jayanta Kumar Rout; Ushasi Banerjee; Sayantan Dasgupta; Arindam Ghosh
Journal:  Indian J Clin Biochem       Date:  2014-01-23

6.  Pustular psoriasis complicated with acute generalized exanthematous pustulosis.

Authors:  Mariam Abbas; Karen Holfeld; Danielle Desjardins; June Zimmer
Journal:  J Dermatol Case Rep       Date:  2014-06-30

Review 7.  Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease.

Authors:  Brenda J Curtis; Katherine A Radek
Journal:  J Invest Dermatol       Date:  2011-09-15       Impact factor: 8.551

8.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

Review 9.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

Review 10.  Psoriasis (chronic plaque).

Authors:  Luigi Naldi; Berthold Rzany
Journal:  BMJ Clin Evid       Date:  2009-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.